Brief: Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results And Clinical Program Updates
07/11/2023 12:08
Nov 7 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023
FINANCIAL
RESULTS AND CLINICAL PROGRAM UPDATES
* FUSION PHARMACEUTICALS INC - PRELIMINARY DATA FOR FPI-2265
((225)AC-PSMA I&T) IN APPROXIMATELY 20 TO 30 PATIENTS ON TRACK
FOR Q1 2024
* FUSION PHARMACEUTICALS - EXPECTS EXISTING CASH, CASH
EQUIVALENTS, INVESTMENTS AS OF SEPT 30 WILL BE SUFFICIENT TO
FUND OPERATIONS INTO Q2 2025
Source text for Eikon: ID:nCNWNMqW7a
Further company coverage: FUSN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary